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ttp://dx.doi.org/10.1016/j.ajpath.2013.12.015Impaired glucose tolerance and type 2 diabetes were induced in guinea pigs to model the emerging
comorbidity of Mycobacterium tuberculosis infection in diabetic patients. Type 2 diabetes mellitus was
induced by low-dose streptozotocin in guinea pigs rendered glucose intolerant by ﬁrst feeding a high-fat,
high-carbohydrate diet before M. tuberculosis exposure. M. tuberculosis infection of diabetic guinea pigs
resulted in severe and rapidly progressive tuberculosis (TB) with a shortened survival interval, more severe
pulmonary and extrapulmonary pathology, and a higher bacterial burden compared with glucose-
intolerant and nondiabetic controls. Compared with nondiabetics, diabetic guinea pigs with TB had an
exacerbated proinﬂammatory response with more severe granulocytic inﬂammation and higher gene
expression for the cytokines/chemokines interferon-g, IL-17A, IL-8, and IL-10 in the lung and for
interferon-g, tumor necrosis factor-a, IL-8, and monocyte chemoattractant protein-1 in the spleen. TB
disease progression in guinea pigs with impaired glucose tolerance was similar to that of nondiabetic
controls in the early stages of infection but was more severe by day 90. The guinea pig model of type 2
diabeteseTB comorbidity mimics important features of the naturally occurring disease in humans. This
model will be beneﬁcial in understanding the complex pathogenesis of TB in diabetic patients and to test
new strategies to improve TB and diabetes control when the two diseases occur together. (Am J Pathol
2014, 184: 1104e1118; http://dx.doi.org/10.1016/j.ajpath.2013.12.015)Supported by American Diabetes Association grant 1-11-BS-08 (R.J.B.)
and NIH grants 1R21AI094123-01 (R.J.B.), 5T32RR007072-10 (B.K.P.),
and 1DP2OD006450 (D.J.O.).
Disclosures: None declared.Host susceptibility to Mycobacterium tuberculosis is inﬂu-
enced by a variety of chronic communicable and non-
communicable diseases that increase the risk of infection and
the development of active tuberculosis (TB) disease. More-
over, M. tuberculosiseinfected patients with concurrent
diseases often have more severe TB, which further compli-
cates treatment responses to conventional antimicrobial
drugs. The risk factors most frequently linked to M. tuber-
culosis susceptibility are HIV infection, malnutrition, to-
bacco use, air pollution, alcoholism, extremes in age, chronic
kidney disease, and diabetes. The highest relative risk for TB
is associated with profound immunosuppression associated
with HIV infection. However, recent epidemiologic evidence
suggests that in the face of a growing diabetes epidemic, the
population-attributable risk of diabetes may be equivalent to
or exceed that of HIV/AIDS. In countries with the highest TBstigative Pathology.
.and diabetes incidences, type 2 diabetes mellitus in particular
may account for up to 20% of active TB cases, whereas<5%
may be attributable to HIV.1,2
Type 2 diabetes accounts for approximately 95% of dia-
betes cases and is associated with obesity, poor diet, and a
sedentary lifestyle, all of which are often linked to urbani-
zation. An estimated 371 million people were diagnosed as
having type 2 diabetes in 2012, with most residing in low-
and middle-income countries. Moreover, an additional 280
million people are prediabetic, many of whom have undi-
agnosed insulin resistance with nondiabetic hyperglycemia
Diabetes Increases Tuberculosis Severityand impaired glucose tolerance (IGT).3 Furthermore, the
global incidence of type 2 diabetes is projected to rise to
approximately 552 million by 2030.4 Evidence in human
studies suggests that glucose control, more than any other
feature of altered metabolism in diabetic patients, inﬂuences
the susceptibility to M. tuberculosis infection, highlighting
the importance of uncontrolled hyperglycemia in TB risk.5
The increased difﬁculty in controlling blood glucose levels
in diabetic patients with TB, combined with poor responses
to antimicrobial drug treatment, has the potential to further
hamper current TB control efforts worldwide.6 An animal
model that more closely mimics the pathogenesis of this
comorbidity in humans is essential for identifying more
effective strategies for antimicrobial drug treatment and for
control of blood glucose levels in diabetic patients with TB.
In addition, the inﬂuence that IGT and insulin resistance
have on TB susceptibility and pathogenesis has not been
adequately investigated.
Currently, the animal models most often used to study the
pathogenesis of TB concurrent with diabetes are inbred
strains of mice treated with high doses of the cytotoxic drug
streptozotocin (STZ).7,8 These models mimic chronic hy-
perglycemia resulting from total insulin deﬁciency, as in
human type 1 diabetes mellitus. Although this strategy has
provided valuable information on how absolute insulin
deﬁciency and persistent hyperglycemia affect active TB
disease, it fails to take into account a variety of other meta-
bolic defects associated with IGT and type 2 diabetes through
dietary manipulation. Unlike murine models, lipid meta-
bolism in the guinea pig more closely resembles that of
humans, making it ideal for studying cardiovascular disease
risks and other consequences of altered glucose and lipid
metabolism associated with type 2 diabetes.9 Moreover, most
mouse strains used to model TB, including those previously
used in diabetes-TB comorbidity studies, fail to respond toM.
tuberculosis infection with the development of pulmonary
and extrapulmonary granulomata with caseous necrosis, as is
typical in humans, as well as guinea pigs, nonhuman pri-
mates, and rabbits.10 The value of the guinea pig TB model
has been further validated recently in studies of natural
transmission ofM. tuberculosis from human patients with TB
to guinea pigs. A subpopulation of guinea pigs exposed to
aerosols from patients with TB developed active TB disease
and an array of clinical and pathologic responses, which more
accurately reﬂects the clinical variation of naturally occurring
M. tuberculosis infection in humans.11
Clinical studies have shown that the increased suscepti-
bility of diabetic patients to M. tuberculosis is accompanied
by an altered host response to infection. Diabetic patients
with active TB have higher bacterial burdens based on
sputum culture and are refractory to ﬁrst-line antimicrobial
combination therapy, with longer time to sputum conversion
and higher mortality rates during therapy.12e14 Diabetic
patients often have atypical radiographic ﬁndings, with
more frequent involvement of lower lung lobes, and some
studies indicate a higher rate of cavitary disease, consistentThe American Journal of Pathology - ajp.amjpathol.orgwith more severe pulmonary pathology.15,16 However, the
impact that diabetes has on the development of extrap-
ulmonary TB in humans is conﬂicting with some studies,
indicating a relative risk similar to or less than that of
nondiabetic patients, whereas others show a predisposition
for extrapulmonary and even miliary disease patterns in
diabetic patients.5,17,18 In patients with TB and poorly
controlled type 2 diabetes, an exaggerated innate and type 1
cytokine response has been demonstrated clinically.19
However, the impact that insulin resistance alone has on
the response to M. tuberculosis infection is unknown. The
goal of this study was to develop an animal model that more
closely mimics the clinical and immunologic manifestations
of diabetes-TB comorbidity in humans.
Materials and Methods
Induction and Conﬁrmation of Glucose Intolerance and
Type 2 Diabetes
Sixty outbred Dunkin-Hartley guinea pigs, weighing 300 to
400 g, were obtained from Charles River Laboratories
(Wilmington, MA) and were maintained in individual hous-
ing. Guinea pigs were divided into three groups: nondiabetic,
IGT, and type 2 diabetic (nZ 20 per group). Eleven weeks
before infection withM. tuberculosis, guinea pigs were fed a
custom-formulated high-fat, high-carbohydrate (HFHC) diet
(Dyets Inc., Bethlehem, PA) ad libitum to induce IGT. The
diet consisted of 18% protein, 30% fat, and 52% carbohy-
drate, with the carbohydrate portion consisting of 45% su-
crose and 55% fructose. The dietary fat composition
consisted of an equivalent kilocalorie per kilogram of beef
tallow and Primex vegetable shortening (Stratas Foods,
Memphis, TN), creating a fatty acid composition of 42%
saturated, 50% monounsaturated, and 8% polyunsaturated
fatty acids. After 8 weeks of the HFHC diet, type 2 diabetes
was induced in half of the guinea pigs with IGT using a single
s.c. injection of STZ to induce subtotal b-cell cytotoxicity.20
STZ treatment consisted of an optimized single dose of 200
mg/kg in citrate buffer (pH 4.5) after anomer equilibration at
4C for 2 hours21 and 20 minutes after pretreatment with an
intramuscular injection of 0.5 mg/kg of the a2-adrenergic
receptor antagonist yohimbine.22 A standardized oral
glucose challenge [oral glucose tolerance test (OGTT)] was
used to assess the severity of glucose intolerance by admin-
istering a 2-g/kg dose of D-glucose (0.5 g/mL) after a 12-hour
fasting period and measuring glucose levels 0, 60, 90, 120,
and 150 minutes after administration using the FreeStyle Lite
glucometer (Abbott Diabetes Care, Alameda, CA), which has
been validated for accuracy in the guinea pig against the
glucose oxidase method, as previously described.23
Infection with M. tuberculosis and Euthanasia
Low-dose aerosol exposure of guinea pigs to M. tubercu-
losis was performed using the Madison chamber aerosol1105
Figure 1 Glucose tolerance is impaired in
guinea pigs with prediabetic IGT and type 2 diabetes
(T2DM). Normal glucose tolerance in nondiabetic
(non-DM) guinea pigs before initiating an HFHC diet
by OGTT (A) and corresponding area under the curve
(AUC) (B). Glucose tolerance was impaired in guinea
pigs fed the HFHC diet alone, with reduced glucose
disposal at 60 minutes of OGTT (C) and an overall
increase in AUC (D) compared with the same guinea
pigs before initiating the diet. A diabetic level of IGT
in T2DM guinea pigs 11 weeks after combinedHFHC/
STZ diabetogenic treatment (E) with a marked in-
crease in AUC (F). Data are given as means  SD.
*P 0.05, **P 0.01, ***P 0.001, and ****P
0.0001 compared with non-DM levels.
Podell et algeneration device (College of Engineering Shops, Univer-
sity of Wisconsin, Madison, WI) calibrated to deliver
approximately 20 bacilli of the H37Rv strain of M. tuber-
culosis (TMC 102; Trudeau Institute, Saranac Lake, NY)
isolated during log phase growth in Proskauer-Beck media.
The course of infection was evaluated in nondiabetic,
glucose-intolerant, and diabetic guinea pigs at the pre-
determined end points of TB disease progression or days 30,
60, or 90 of infection or to humane end points, and then the
animals were euthanized (n Z 5 per group per time point).
On day 30 of infection, 7 of 20 diabetic guinea pigs remained
and were euthanized owing to declining clinical condition.
Euthanasia was performed by anesthetic induction with 40Table 1 Metabolic Parameters from Non-DM, Glucose-Intolerant, and T
30, 60, and 90 Days after Infection
Parameter Model Day 0 Da
TG (mg/dL) Non-DM 34.7  9.4 5
IGT 93.1  63.7* 6
T2DM 101  47* 5
FFA (mmol/L) Non-DM 132.3  24.8
IGT 146.6  47.5 40
T2DM 172.6  47.4* 45
AGE (mg/mL) Non-DM 1.079  0.181 1.
IGT 0.973  0.011 1.
T2DM 1.163  0.168 2.
Data are given as means  SD.
*P  0.05 compared with non-DM levels.
yP  0.05, yyP  0.001, and yyyP  0.0001 compared with preinfection levels
ND, not determined; non-DM, nondiabetic; T2DM, diabetic; TG, triglyceride.
1106mg of ketamine and 1 mg of diazepam before i.p. injection of
an overdose of 1.5 mL/kg of sodium pentobarbital.
Histopathologic Evaluation and Lesion Burden
Determination
To determine the impact that IGT and diabetes had on TB
disease progression, histopathology was evaluated and
lesion burden quantiﬁed on days 30, 60, and 90 of M.
tuberculosis infection. Tissues were ﬁxed in 4% buffered
paraformaldehyde. Standardized sampling of the lung was
performed by midsagittal sectioning of the left caudal lung
lobe from each guinea pig at a predetermined anatomical2DM Guinea Pigs before Infection with M. tuberculosis (Day 0) and
y 30 Day 60 Day 90
8.4  16.3 40.59  19.3 ND
6.9  44.1 77.1  42.1 ND
2.2  13.9 ND ND
380  46.2yyy 260.6  8.6y 252.7  25.4y
6.1  84yyy 256.9  19.2y 240.3  16.6y
4.2  90.7yyy ND ND
266  0.188 1.125  0.179 0.956  0.122
186  0.273 1.007  0.094 0.987  0.14
522  0.532yy ND ND
.
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Figure 2 Infection with M. tuberculosis further
impairs glucose tolerance in nondiabetic (non-DM),
HFHC-fed only, and diabetic (T2DM) guinea pigs.
OGTT on day 30 of infection (A) showed ampliﬁca-
tion of IGT in non-DM, HFHC-fed only, and T2DM
guinea pigs due to M. tuberculosis infection with an
increased area under the curve (AUC) (B) compared
with preinfection values. On day 60 of infection (C),
glucose tolerance was comparable with preinfection
levels in non-DM guinea pigs, whereas IGT and an
increased AUC (D) remained in guinea pigs with
preexisting IGT. Similarly, IGT persisted on day 90 of
infection (E) in guinea pigs with preexisting IGT as
indicated by an elevated AUC (F), whereas overall
glucose tolerance was comparable with preinfection
levels in non-DM controls, although blood glucose
levels remained elevated in this group 2 hours after
administration. Data are given as means  SD.
*P 0.05, **P 0.01, and ***P 0.001 compared
with non-DM preinfection levels; yP  0.05, yyP 
0.01 compared to non-DM, infected levels.
Diabetes Increases Tuberculosis Severitylocation, irrespective of visible lung lesions. The head of the
spleen from each animal was also uniformly sectioned for
histopathologic evaluation. The tissues were parafﬁn
embedded, and 5-mm sections were stained with H&E for
histopathologic evaluation using routine methods.
Morphometric analysis was performed using an Eclipse 80i
microscope (Nikon Instruments, Melville, NY) and Stereo
Investigator software version 10.02 (MBF Bioscience,
Williston, VT), with tissue area and lesion area estimated
using the area fraction fractionator method and expressed as
a percentage ratio of lesion to total tissue area, as previously
described.24
Quantiﬁcation of Tissue Bacterial Burden
Lung, spleen, and liver were homogenized in 1 mL of PBS,
plated in serial dilutions on nutrient 7H11 agar, and incu-
bated at 37C for 3 to 6 weeks. Colony-forming units were
log transformed and are expressed as colony-forming units
per gram of tissue. In addition, the intrathoracic trachea was
removed at necropsy, ﬂushed with 1 mL of PBS, and plated
on 7H11 agar undiluted. Data are expressed as either posi-
tive or negative for M. tuberculosis growth.
Quantiﬁcation of Serum Lipids
Total serum triglycerides were quantiﬁed by sequential
enzymatic conversion with lipoprotein lipase, glycerolThe American Journal of Pathology - ajp.amjpathol.orgkinase, and glycerol phosphate oxidase, followed by
peroxidase-mediated colorimetric change (CaymanChemical
Co., Ann Arbor, MI) measured spectrophotometrically at an
absorbance of 450 nm. Total serum free fatty acids (FFAs)
were quantiﬁed by sequential enzymatic conversion with
ascorbate oxidase and acyl CoA oxidase, followed by
peroxidase-mediated generation of ﬂuorescence (Cayman
Chemical Co.) measured spectrophotometrically at excitation
530 nm and emission 585 nm, as previously described.23
Quantiﬁcation of Tissue and Serum Advanced Glycation
End Products
Lung tissue was mechanically homogenized in 1 mL of
PBS and then was centrifuged to remove insoluble ma-
terial, and the supernatant was used for advanced glyca-
tion end product (AGE) detection. Serum and cell lysate
from lung homogenate were assayed for total protein by
the bicinchoninic acid method and were diluted to 10 mg/
mL for AGE detection by enzyme-linked immunosorbent
assay (ELISA) (Cell Biolabs Inc., San Diego, CA).
Quantiﬁcation was performed by interpolation from a
standard curve derived from AGE-modiﬁed bovine serum
albumin, and data are expressed as microgram of AGE-
modiﬁed protein per milliliter. Antibodies used in this
assay detect glycolaldehyde-derived AGEs, including two
of the most biologically prevalent: carboxymethyl-lysine
and pentosidine.1107
Figure 3 TB is more severe in guinea pigs with type 2 diabetes (T2DM). A: Markedly reduced survival in T2DM guinea pigs and intermediate, but nonsig-
niﬁcant, susceptibility seen in guinea pigs with IGT. B: An approximately threefold increase in lung disease severity in T2DM guinea pigs on day 30 of infection
was measured by lesion burden, whereas no signiﬁcant differences were present between glucose-intolerant and nondiabetic (non-DM) controls. C: Spleen lesion
burden was markedly increased in T2DM guinea pigs on day 30 of infection, whereas no signiﬁcant differences were present between glucose-intolerant and non-
DM controls. Compared with normal granuloma morphology in the lung of non-DM guinea pigs (D), there is much higher granulocyte inﬁltration (arrows) and
disruption of granuloma architecture in T2DM guinea pigs (E). Compared with typical large and discrete granulomas (arrow) in the spleen of non-DM guinea pigs
(F), T2DM guinea pigs have a widespread miliary pattern of lesion dissemination in the spleen consisting of small and coalescing granulomas (arrows) (G). Data
are given as means  SD (AeC). *P  0.05, **P  0.01 compared with non-DM levels. Scale bars: 100 mm (DeG). H&E (DeG). N, necrosis.
Podell et alRNA Isolation from Lung Tissue
The pulmonary circulation was perfused with 40 U/mL of
RNasin RNase inhibitor (Promega Corp., Madison, WI) in
HBSS at the time of necropsy. Perfused lung was collected
in incomplete Dulbecco’s modiﬁed Eagle’s medium and
was maintained at 4C unless otherwise indicated. Tissues
were digested with 0.7 mg/mL of collagenase D and 100 U
of DNaseI at 37C for 30 minutes and then were pushed
through a 70-mm cell strainer. Viable cells were separated
from necrotic cell debris using Ficoll-Paque PREMIUM
medium (GE Life Sciences, Pittsburg, PA) and were washed
twice in HBSS, and 1 mL of TRIzol reagent (Life Tech-
nologies, Grand Island, NY) was added to the recovered
viable cells. RNA isolation with TRIzol reagent was per-
formed as instructed by the manufacturer, followed by
treatment with 10 U of DNaseI and recovery with an ad-
ditional phenol/chloroform separation and sodium acetatee
ethanol precipitation. RNA integrity was assessed using the
RNA 6000 nano chip (Agilent Technologies Inc., Santa
Clara, CA), and samples with an RNA integrity number
greater than 5 were used for relative gene expression.
Relative Gene Expression by Quantitative RT-PCR
The inﬂuence of IGT and diabetes on the immune response
to M. tuberculosis infection was measured by relative gene
expression of selected key cytokines. After cDNA synthesis,
quantitative RT-PCR was performed using the SYBR Green
detection kit (Bio-Rad Laboratories, Hercules, CA) using
the Bio-Rad CFX-96 real-time thermal cycler per manu-
facturer instructions, with each reaction containing 0.2
mmol/L of each primer and 50 ng of cDNA template. Under1108these reaction conditions, primer design was optimized for
equivalent ampliﬁcation efﬁciencies. Gene expression was
normalized to two reference genesdhypoxanthine-guanine
phosphoribosyltransferase (HPRT ) and TATA-box binding
protein (TBP)d both of which were validated for consistent
expression under these experimental conditions. The HPRT,
IL-12p40, interferon-g (IFN-g), tumor necrosis factor-a
(TNF-a), IL-1b, transforming growth factor-b, and FoxP3
primer sequences used in this study are previously publish-
ed.25e27 TBP, IL-17A, IL-23, monocyte chemoattractant
protein-1 (MCP-1), and IL-10 primers were designed using
transcripts from the EMBL Ensembl annotated genome
browser28 for the guinea pig with the aid of Primer3 primer
design software version 2.2.3,29 and primers targeting IL-4
were designed from the recently published sequence.30 The
primer sequences (forward and reverse) are as follows: TBP
(ENSCPOT00000001200), 50-CCAAGCGGTTTGCTGC-
TGTA-30 and 50-GGCTCCTGTGCACACCATCTT-30; IL-10
(ENSCPOT00000009023), 50-GCCTTTGGCAGGGTGAA-
GAC-30 and 50-GGCTTGGCASACCCAGGTAAC-30; IL-
17A (ENSCPOT00000010600), 50-AATGCCGTTACT-
CGGGCTGT-30 and 50-AGCGGGCAGTTCTGAGGTTC-30;
MCP-1 (ENSCPOT00000013601), 50-AGCAGCAGGTG-
TCCCCAAGA-30 and 50-TCTCTGGTCCAGTTTGGCAA-
TG-30; IL-23 (ENSCPOT00000015072), 50-GCAACCAC-
CACACCTTGCAAGAAA-30 and 50-ATCAGCAAAGACG-
TCCGTGACCAGC-30; and IL-4 (NCBI NM_001257263),
50-GCAACCACCACACCTTGCAAGAAA-30 and 50-ATC-
AGCAAAGACGTCCGTGACCAGC-30. RNA isolates
without reverse transcriptionwere ampliﬁed for each animal to
ensure a lack of contaminating genomic DNA, and all assays
performed included no-template controls. Data are expressed
as normalized fold expression on a log2 scale.ajp.amjpathol.org - The American Journal of Pathology
Figure 4 Guinea pigs with diabetes (T2DM)
have a higher bacterial burden. A: T2DM guinea
pigs on day 30 of infection had a much higher
bacterial burden in pulmonary and extrapulmonary
organs. B: There was higher frequency of M.
tuberculosis growth from tracheal wash ﬂuid of
T2DM guinea pigs, exceeding positive samples
from guinea pigs with IGT compared with no
growth in nondiabetic (non-DM) controls. There
were no signiﬁcant differences in tissue bacterial
burden on day 60 of infection between glucose-
intolerant and non-DM guinea pigs (C) and
similar tracheal wash culture results, which
declined in guinea pigs with IGT (D). E: By day 90
of infection, extrapulmonary burden declined in
non-DM guinea pigs, whereas it was persistently
elevated in guinea pigs with IGT. F: All tracheal
wash cultures from non-DM and glucose-intolerant
guinea pigs were negative on day 90 of infection.
Data are given as means  SD (A, C, and E).
*P  0.05, **P  0.01, and ***P  0.001
compared with non-DM levels. CFU, colony-forming
unit.
Diabetes Increases Tuberculosis SeverityQuantiﬁcation of Leukocyte Phenotype in Tissue by
Flow Cytometry
Single-cell suspensions from lung, tracheobronchial lymph
node, and spleen were prepared as previously described.31
Cell suspensions were labeled with antieguinea pig CD4-
RPE, CD8-FITC, pan T-celleAPC, CD45-FITC, MIL4
(granulocytes), MR1 (macrophages), and MHC-II antibodies
(AbD Serotec, Raleigh, NC) as previously described.32 Un-
conjugated antibodies were detected with a secondary anti-
mouse IgG antibody conjugated with RPE ﬂuorochrome for
CD45 detection on CD8 T cells, MHC-II, and MIL4 anti-
bodies and with FITC ﬂuorochrome for the MR1 antibody.
Data acquisition was performed using the LSR II ﬂow cy-
tometer (BD Biosciences, San Jose, CA), and data were
analyzed using FACSDiva software version 7.0 (BD Bio-
sciences) using a minimum of 100,000 events. Compensation
for spectral overlap was performed as previously described.32Data Analysis
Analysis was performed using SAS software version 9.3
(SAS Institute, Inc., Cary, NC). A one-factor analysis of
variance was used for glucose tolerance testing, morpho-
metric microscopy, tissue bacterial culture, and cytokine
data with log transformation to correct for unequal variance,
and the Tukey honestly signiﬁcant difference was used for
pairwise comparisons. A two-factor analysis was used onThe American Journal of Pathology - ajp.amjpathol.orgthe log-transformed ﬂow cytometry data, and the Tukey
honestly signiﬁcant difference was used for pairwise com-
parisons between groups at each time point. To determine
differences between survival curves, a log-rank test with
Wilcoxon adjustment for multiple comparisons was used.
Signiﬁcance was set at P  0.05.Results
HFHC Diet Impairs Glucose Tolerance in Guinea Pigs
Guinea pigs fed an HFHC diet for 8 weeks consistently
developed IGT as determined by OGTT. Delayed glucose
use resulted in abnormally elevated blood glucose levels as
early as 60 minutes after glucose challenge as expressed as a
signiﬁcant increase in total area under the curve (Figure 1, C
and D) compared with OGTT before initiating the diet
(Figure 1, A and B).
HFHC Diet Combined with STZ Induces Type 2 Diabetes
in Guinea Pigs
OGTT performed 2 weeks after STZ treatment of guinea
pigs fed the HFHC diet showed fasting hyperglycemia and
further exacerbation of IGT, with glucose levels remaining
high 150 minutes after glucose challenge (Figure 1, E and
F), criteria consistent with human type 2 diabetes.33 The
impact of diabetogenic treatments on serum biochemical1109
Figure 5 Guinea pigs with type 2 diabetes
(T2DM) respond to M. tuberculosis infection with a
more robust type 1 cytokine response. Relative
gene expression of cytokines promoting a Th1-
biased T-cell response was measured by quantita-
tive RT-PCR. Lung IFN-g and IL-17 expression and
spleen IFN-g expression were higher in T2DM
guinea pigs infected with M. tuberculosis on day 30
of infection. Elevated IFN-g expression was not
seen in guinea pigs with IGT until day 90 of
infection. No signiﬁcant differences were observed
in IL-12p40 or IL-23 expression at any time point
evaluated. Data are given as log2  SEM.
*P  0.05, ***P  0.001 compared with nondia-
betic (non-DM) levels.
Podell et alparameters after a 12-hour fasting period is summarized in
Table 1. Guinea pigs with IGT fed the HFHC diet only for
11 weeks and guinea pigs with 3 weeks of uncontrolled
diabetes had elevated fasting triglyceride levels before M.
tuberculosis infection. FFA levels were signiﬁcantly
elevated only in the diabetic guinea pigs before M. tuber-
culosis infection.1110Infection with M. tuberculosis Impairs Glucose
Tolerance in Nondiabetic, HFHC-Fed Only, and Diabetic
Guinea Pigs
At day 30 of infection, TB induced IGT in nondiabetic
guinea pigs, with signiﬁcantly higher levels 120 minutes
after glucose administration and an overall increase in areaFigure 6 Guinea pigs with type 2 diabetes
(T2DM) respond with an elevated innate chemo-
kine/cytokine response early in M. tuberculosis
infection. Relative gene expression of innate cy-
tokines and chemokines most involved in TB
pathogenesis was measured by quantitative RT-
PCR. Expression of the neutrophil and macro-
phage chemokines IL-8 and MCP-1, respectively, as
well as splenic TNF-a expression were signiﬁcantly
elevated in guinea pigs with T2DM on day 30 of
infection. In contrast, elevated expression of IL-
1b and TNF-a occurred only on day 90 of infection
in guinea pigs with IGT. Data are given as log2 
SEM. *P  0.05, **P  0.01, and ***P  0.001
compared with nondiabetic (non-DM) levels.
ajp.amjpathol.org - The American Journal of Pathology
Figure 7 Increased IL-10 expression does not
impair the inﬂammatory response in type 2 diabetic
(T2DM) guinea pigs. Relative gene expression of
cytokines and transcription factors that oppose the
cell-mediated response during TB were measured by
quantitative RT-PCR. A productive type 1 cytokine
response persisted in T2DM guinea pigs despite
elevated IL-10 expression on day 30 of infection
with M tuberculosis. IL-4 expression, as an indicator
of Th2 T-cell differentiation, or FoxP3 expression,
as an indicator of regulatory T-cell differentiation,
did not differ between nondiabetic (non-DM),
insulin-resistant, or T2DM states at any time point
evaluated. Data are given as log2 SEM. *P 0.05
compared with non-DM levels. TGF-b, transforming
growth factor-b.
Diabetes Increases Tuberculosis Severityunder the curve compared with preinfection glucose
tolerance (Figure 2, A and B). IGT was more severe
in HFHC-fed animals and diabetic guinea pigs after
M. tuberculosis infection, with total area under the curve
exceeding preinfection, postdiabetogenic treatment levels
(Figure 2, A and B). Although IGT persisted in HFHC-fed
alone guinea pigs through days 60 and 90 of infection,
total area under the curve was not signiﬁcantly different
from preinfection glucose tolerance in nondiabetic guinea
pigs on days 60 and 90 of infection (Figure 2, CeF).
However, despite minimal difference in total area under
the curve, IGT was evident at the end point of OGTT in
nondiabetic guinea pigs (Figure 2, E and F). Infection with
M. tuberculosis also markedly increased serum FFA levels
in all the groups. Serum FFA levels were highest on day
30 of infection and subsided as chronic infection was
established (Table 1).
AGEs Accumulate When Diabetes and TB Are Combined
Serum AGEs were elevated above preinfection levels by
approximately threefold on day 30 of infection only in
diabetic guinea pigs, whereas no difference was evident
between nondiabetic guinea pigs and those with IGT on
days 30, 60, or 90 of M. tuberculosis infection (Table 1).
Increased pulmonary tissue AGEs were present in M.
tuberculosiseinfected nondiabetic, glucose-intolerant, and
diabetic guinea pigs to a similar degree (Table 1) at
approximately threefold over uninfected nondiabetic lung
(data not shown).The American Journal of Pathology - ajp.amjpathol.orgDiabetic Guinea Pigs Develop Rapidly Progressive TB
Disease
Progression of TB was rapid in diabetic guinea pigs, with
65% mortality before day 30 of infection and median sur-
vival of 25 days (Figure 3A). Guinea pigs with IGT showed
intermediate, but not statistically signiﬁcant, mortality rates
compared with nondiabetic controls. Mortality in guinea
pigs with IGT was 50% before termination of the study on
day 145, with median survival of 95 days. Guinea pigs with
IGT and infected with M. tuberculosis were euthanized
owing to respiratory distress and had developed marked
cranial mediastinal and tracheobronchial lymph node
enlargement with compression of primary bronchi. No
mortality occurred in nondiabetic guinea pigs before the
terminal end point on day 145 of infection.
M. tuberculosis Infection in Guinea Pigs with Diabetes
Accelerates Bacilli Dissemination and Exacerbates TB
Disease Severity
Pulmonary lesion burdens were markedly increased in
diabetic guinea pigs, with a 2.7-fold increase in mean
percentage involvement over nondiabetic controls.
Although pulmonary lesions were higher in guinea pigs
with IGT on day 30, this difference was not statistically
signiﬁcant, and no signiﬁcant differences were present on
days 60 and 90 of infection between glucose-intolerant and
nondiabetic guinea pigs (Figure 3B). In contrast to typical
well-structured granulomas of nondiabetic guinea pigs and1111
Figure 8 Activated macrophages and granulocytes are increased in diabetic (T2DM) guinea pigs on day 30 of M tuberculosis infection. Total CD4þ or CD8þ
TCRþ T cells and MHCII low- or high-expressing macrophages were quantiﬁed by ﬂow cytometry and normalized to per gram of tissue in lung, lymph node (LN),
and spleen and then expressed as percentage activated based on proportions of CD45high CD4þ and CD8þ lymphocytes and MHCIIhigh macrophages. AeC: The
proportion of activated CD4 T cells decreased in nondiabetic (non-DM) and glucose-intolerant guinea pigs on day 60 of infection but was equally elevated on
day 90 of infection in all organs in non-DM and glucose-intolerant guinea pigs. DeF: There were no differences in CD8 T-cell activation at any time point
among non-DM, glucose-intolerant, and T2DM guinea pigs. GeI: Higher proportions of activated macrophages were present in T2DM guinea pigs in lung and
LN on day 30 of infection. JeL: Granulocytes as a proportion of total leukocytes counted per gram of tissue were increased in the lung of T2DM guinea pigs.
Data are given as means  SD. *P  0.05 compared with non-DM levels.
Podell et althose with IGT (Figure 3D), diabetic guinea pigs had
marked granulocytic inﬂammation that disrupted lung
granuloma architecture, often resulting in airway erosions
(Figure 3E). Splenic lesion burden, as a measure of
extrapulmonary TB disease, was increased in diabetic
guinea pigs on day 30 of infection, reaching as high as
97% involvement (Figure 3C). In addition to extensive
involvement, guinea pigs with diabetes had altered lesion
morphology characterized by widely disseminated yet
smaller and often coalescing aggregates of macrophages
(Figure 3G) compared with nondiabetic controls
(Figure 3F). Progressive lesions developed in the lymph
nodes draining the lungs in all guinea pigs regardless of
their diabetic state.1112Diabetic Guinea Pigs Have a Higher Bacterial Burden
On day 30 of infection, diabetic guinea pigs had approxi-
mately 2 log10 higher bacterial burdens in all tissues eval-
uated compared with nondiabetic controls and guinea pigs
with IGT (Figure 4A). Although no signiﬁcant differences
were present on day 60 of infection (Figure 4C), the bac-
terial burden was lower in spleen and liver of nondiabetics
on day 90 compared with guinea pigs with IGT, whose
extrapulmonary burden remained elevated (Figure 4E). The
higher lung bacterial burden in diabetic guinea pigs was
accompanied by increased shedding of bacilli into the upper
airways. Although M. tuberculosis could not be isolated
from the tracheal wash ﬂuid of any nondiabetic controlsajp.amjpathol.org - The American Journal of Pathology
Diabetes Increases Tuberculosis Severity(nZ 4) on day 30 of infection,M. tuberculosis was cultured
from two of four guinea pigs with IGT and ﬁve of eight
diabetic guinea pigs (Figure 4B). As chronic infection was
established, the frequency of viable bacilli cultured from the
tracheal wash of guinea pigs with IGT was reduced.
Tracheal washes were culture positive from one nondiabetic
and glucose-intolerant guinea pig on day 60 of infection
(Figure 4D), but all were negative by day 90 (Figure 4F).
Guinea Pigs with IGT and Diabetes Respond to M.
tuberculosis Infection with Altered Proinﬂammatory
and Anti-Inﬂammatory Cytokine Proﬁles
On day 30 of infection, elevations in cytokine and che-
mokine expression in the lungs of diabetic guinea pigs
included IL-12p40 (2.3-fold), IFN-g (4.7-fold), IL-17A
(4.3-fold), IL-8 (5.6-fold), and IL-10 (12.6-fold) compared
with nondiabetic controls (Figures 5, 6, and 7). In contrast,
nondiabetic guinea pigs and those with IGT had similar
cytokine proﬁles early in infection and through day 60
(Figures 5, 6, and 7), except for a 4.0- and 12.6-fold in-
crease in TNF-a (PZ 0.1) and IL-1b, respectively, on day
90 of infection in guinea pigs with IGT compared with
nondiabetic controls (Figure 6). Diabetic guinea pigs had
elevated IFN-g (5.8-fold), TNF-a (4.3-fold), IL-8 (39.8-
fold), and MCP-1 (11.0-fold) levels in the spleen on day 30
of infection, whereas guinea pigs with IGT had elevated
TNF-a (3.0-fold) compared with nondiabetic controls
(Figures 5 and 6). Differences in cytokine expression in the
spleen on day 90 of infection were present in guinea pigs
with IGT with elevated IFN-g (4.4-fold), TNF-a (4.5-fold),
and transforming growth factor-b (6.2-fold) levels
(Figures 5, 6, and 7). Expression of FoxP3 and IL-4 did not
differ between any groups at any point throughout the study
(Figure 7).
Guinea Pigs with Diabetes Have Higher Levels of
Macrophage Activation and Neutrophil Inﬁltration
Early in Disease, Whereas Innate Immune Cell
Phenotypes Increase Late in Disease in Guinea Pigs
with IGT
Absolute quantiﬁcation of immune cell phenotypes per gram
of lung, lymph node, and spleen is depicted in Table 2. Dia-
betic guinea pigs responded toM. tuberculosis infection with
higher total numbers of activated MHCIIhigh macrophages
in lung, lymph node, and spleen (Table 2) and a greater
proportion of activated macrophages out of all macro-
phage cells recovered from lung and lymph node
compared with nondiabetic and glucose-intolerant con-
trols (Figure 8, G and H). This correlated with higher
total numbers of activated CD45high CD4 T cells from the
lymph node of diabetic guinea pigs, although the per-
centage of activated CD45high T cells out of total CD4
T cells recovered did not differ (Figure 8, AeC). InThe American Journal of Pathology - ajp.amjpathol.orgaddition, diabetic guinea pigs had a higher proportion of
granuloyctes in the lung on day 30 of infection compared
with nondiabetic controls (Figure 8J). In contrast, guinea
pigs with IGT had lower cell numbers of all phenotypes
recovered from lymph node on day 30 of infection, but
higher numbers of activated MHCIIhigh macrophages as
well as granulocytes were present on day 90 of infection.
An overall decrease in the proportion of activated
CD45high CD4 T cells occurred in all organs in nondia-
betic guinea pigs and those with IGT between days 30
and 60 of infection but increased again on day 90 of
infection (Figure 8, AeC).Discussion
This study represents the ﬁrst model of type 2 diabetes in the
guinea pig and the ﬁrst description of M. tuberculosis
infection in an animal model with diet-induced IGT or type
2 diabetes. The guinea pig model was chosen to better
mimic the comorbidity of diabetes and TB in humans based
on the guinea pig response to M. tuberculosis infection and
similarities to human glucose and lipid metabolism
compared with mice or rats. The most common indicator of
systemic insulin resistance in human patients is delayed use
of glucose, referred to as IGT, as measured by OGTT. In
this study, guinea pigs fed an HFHC diet developed IGT
evidenced by an elevated 1-hour postload blood glucose
level during OGTT, a measurement recently shown to pre-
dict early insulin resistance and b-cell dysfunction in pa-
tients.34 In addition, guinea pigs developed serum lipid
alterations, including elevated fasting triglyceride and FFA
levels, consistent with insulin resistance similar to that seen
in humans.35 In humans, the progression from prediabetic,
IGT, and insulin resistance to type 2 diabetes is gradual and
can take years.36 Consequently, low-dose treatment with the
cytotoxic drug STZ in these studies was included to accel-
erate the rate of b-cell loss in guinea pigs with IGT. The
combination of the HFHC diet and low-dose STZ use
consistently induces fasting hyperglycemia and blood
glucose levels exceeding 200 mg/dL in 2-hour OGTT as
early as 14 days after STZ treatment, data consistent with
the diagnostic standards established for patients with type 2
diabetes.33
Severe systemic inﬂammation in nondiabetic patients is
often associated with hyperglycemia and IGT mediated, in
part, by proinﬂammatory cytokines, especially TNF-a. The
pathogenesis of cytokine-mediated hyperglycemia and IGT
is directly linked to the release of FFAs, which are potent
mediators of insulin resistance.37e39 In this study, IGT was
induced by M. tuberculosis infection alone even in
nondiabetic guinea pigs, as previously described.23 M.
tuberculosis infection in diabetic and nondiabetic guinea
pigs fed the HFHC diet only further exacerbated IGT. This
ﬁnding paralleled the marked elevations in serum FFA
levels in infected guinea pigs, which exceeded the modest1113
Table 2 Immune Cell Phenotypes in Absolute Number as Measured by Flow Cytometry in Lung, Lymph Node, and Spleen at 30, 60, and 90
Days of Infection
Cell phenotype Model
Lung
30 days 60 days 90 days
CD4 TCR Non-DM 3.09  0.58 8.13  1.04 5.31  1.12
IGT 3.24  0.33 9.92  1.65 8.05  0.83
T2DM 2.00  0.22
CD4 TCR CD45high Non-DM 2.20  0.41 0.88  0.26 4.03  0.94
IGT 2.24  0.22 1.08  0.19 5.79  0.70
T2DM 1.47  0.16
CD8 TCR Non-DM 2.42  0.58 2.35  0.22 3.06  0.92
IGT 2.53  0.42 3.91  0.66 5.34  0.74
T2DM 1.78  0.16
CD8 TCR CD45high Non-DM 1.07  0.27 0.60  0.09* 0.91  0.23
IGT 1.15  0.24 1.11  0.18 2.12  0.38
T2DM 0.60  0.06
MHCIIlow MAC Non-DM 51.00  5.32 47.08  7.02 84.16  13.95
IGT 45.86  3.28 49.64  8.02 154.20  14.36
T2DM 35.96  3.87
MHCIIHigh MAC Non-DM 4.62  1.63y 8.36  1.88 9.73  2.79
IGT 5.32  0.59 9.07  1.40 19.14  6.24
T2DM 8.44  1.44
MIL4 Gran Non-DM 11.39  1.20 8.08  1.55 14.91  2.99*
IGT 12.83  1.26 8.70  2.05 25.68  4.58
T2DM 15.86  2.71
B cell Non-DM 41.20  5.20 42.94  6.99 74.74  11.33**
IGT 41.92  2.54 47.38  7.30 138.4  14.74
T2DM 27.96  2.29
(table continues)
Results are expressed as means  SD at 105 cells and normalized to per gram of tissue. Blank cells corresponding to T2DM guinea pigs on days 60 and 90 of
infection were not determined.
*P  0.05, **P  0.01, ***P  0.001 compared with IGT.
yP  0.05, yyP  0.01, and yyyP  0.001 compared with T2DM.
Gran, granulocyte; MAC, macrophage; non-DM, nondiabetic; T2DM, diabetic.
Podell et alelevations associated with diabetes induction before
infection. In addition, elevations in FFA levels reﬂected
increased cytokine expression during the early stages of
infection, which subsided on day 60 of infection, when
innate cytokine expression was low. The relationship be-
tween cytokine expression and FFA concentrations was
also reﬂected on day 90 of M. tuberculosis infection in
guinea pigs with IGT, which also correlated with increased
TNF-a and IL-1b expression. IGT and insulin resistance
with hyperglycemia has been previously reported in pa-
tients with active TB, which may be explained by elevated
proinﬂammatory cytokines consistent with these data. The
clinical signiﬁcance of IGT and hyperglycemia induced
by M. tuberculosis infection is that it further complicates
the diagnosis and treatment of diabetes in patients with
TB.40e43
Overt diabetes had a profound effect on TB progres-
sion in this study. An overall increase in disease severity,
characterized by a signiﬁcantly higher bacterial load and
more severe and rapidly progressive pulmonary and
extrapulmonary disease, contributed to decreased sur-
vival in diabetic guinea pigs with TB. These ﬁndings are
consistent with reports of more severe pulmonary TB in1114diabetic patients.15,16 Despite the conﬂicting evidence in
patients,5,10,17,18 more severe and rapidly progressing
extrapulmonary disease in diabetic guinea pigs was a
consistent ﬁnding. The altered pattern of lesion dissem-
ination in the spleen of diabetic guinea pigs resembles
miliary TB, a pattern of disease that is associated with
increased mortality rates, especially in severely immu-
nocompromised patients with TB.44 M. tuberculosis
infection in diabetic guinea pigs also resulted in
increased shedding of bacilli into the tracheal lumen at
the predetermined end points. M. tuberculosis was
cultured from the tracheal washes of diabetic guinea pigs
with greater frequency than nondiabetic guinea pigs and
those with IGT. The low frequency of animal-to-animal
transmission of M. tuberculosis in normal guinea pigs
is likely related to the failure to routinely develop open
cavitary lesions, which typically harbor large numbers of
bacilli.10,45 The present data indicate that diabetes in-
duction increases the frequency of airway shedding of M.
tuberculosis, even in the absence of cavitation, which
may be related to a higher pulmonary bacterial load and/
or an alteration in the diabetic airway microenviron-
ment.46,47 With the increasing interest in natural M.ajp.amjpathol.org - The American Journal of Pathology
Lymph node Spleen
30 days 60 days 90 days 30 days 60 days 90 days
16.32  1.53** 52.10  9.48 21.71  7.07 6.86  0.84 29.73  8.56 10.09  1.74
5.75  1.33yy 46.30  8.92 19.86  5.22 7.65  1.43 28.20  5.01 13.59  5.25
24.59  4.55 6.30  0.67
11.38  0.87* 17.96  3.85 13.61  3.81 3.08  0.44 1.85  0.72 6.10  1.23
3.96  1.18yy 15.50  4.26 13.69  4.21 4.07  0.99 2.12  0.81 8.06  3.31
15.31  3.14 3.42  0.65
11.91  1.94* 12.29  3.11 8.49  1.95 6.95  0.85 16.90  4.63 18.84  5.03
3.92  0.73yyy 16.29  4.00 13.60  4.48 7.00  1.41 17.49  5.53 17.78  7.01
21.38  3.97 5.76  1.68
6.81  1.18 25.06  13.60 6.36  1.98 0.81  0.09 2.66  0.93 2.62  1.24
2.45  0.42yyy 10.53  2.37 11.20  3.92 0.96  0.19 2.60  1.04 2.63  0.84
14.01  2.64 0.73  0.34
145.9  16.14 157.5  24.26 150.1  46.24 58.92  7.71 106.3  23.43 115.9  23.42
100.1  10.94y 113.9  17.38 199.8  17.44 68.00  7.18 109.6  21.43 185.7  57.52
167.1  12.11 93.03  15.16
47.87  18.57 89.46  32.07 26.70  6.62 6.42  1.99 20.50  5.38 15.12  2.35
22.42  6.47y 56.28  4.97 86.68  8.30 5.28  1.34y 17.43  3.30 22.50  5.05
103.6  31.98 19.18  6.75
133.0  25.87 92.22  31.12** 34.54  10.69 3.49  0.47 6.24  1.78 5.47  0.70
92.42  17.41y 35.22  15.65 35.22  15.65 3.71  0.79 5.94  1.31 8.45  3.02
178.3  33.21 5.98  1.41
91.46  13.54 163.3  39.14 123.1  37.71 28.10  2.56 85.10  19.44 94.06  12.57
55.70  8.90y 101.6  7.24 188.0  25.59 40.70  9.42 89.16  20.30 149.5  48.68
106.3  14.21 60.40  9.78
Table 2 (continued)
Diabetes Increases Tuberculosis Severitytuberculosis transmission from humans to animals or
between animals,11 the diabetic guinea pig may represent
a viable animal-to-animal transmission model, which
warrants further investigation.
In contrast, IGT in guinea pigs seemed to have little
effect on TB disease progression in the early stages of
disease. Although the initial pulmonary burden was higher
in guinea pigs with IGT, the differences were not statis-
tically signiﬁcant, and the number of activated CD45high
lymphocytes in the lung as well as cytokine expression
were comparable with nondiabetic controls. Differences in
response to M. tuberculosis infection in guinea pigs with
IGT were not seen until the chronic stages of infection.
On day 90, TNF-a and IL-1b expression and the extrap-
ulmonary bacterial burden in guinea pigs with IGT were
higher than in nondiabetic controls. Recently, an
increased prevalence of IGT and insulin resistance has
also been recognized in patients with TB; however, it is
unknown whether these metabolic alterations are a
consequence of systemic insulin resistance mediated by
M. tuberculosis infection.48 These results provide the ﬁrst
experimental evidence that IGT similar to a prediabetic
state also increases TB disease severity, a ﬁnding thatThe American Journal of Pathology - ajp.amjpathol.orgwarrants further investigation in animal models and
humans.49 Although guinea pigs with IGT did not develop
TB disease that progressed as rapidly as in diabetic guinea
pigs, active inﬂammation persisted, which accounted for
more severe clinical disease in the chronic stages of
infection. In this study, the more severe TB disease in
guinea pigs with hyperglycemia as a result of IGT are
similar to previous studies showing that TB disease
severity is increased even in nondiabetic guinea pigs
with repeated postprandial hyperglycemia.23 Moreover,
the present results are similar to those described in
diabetic humans and STZ-treated mice with chronic hy-
perglycemia, which suggest that poor glycemic control is
an important determinant of TB disease risk.7,19
Aside from the increased severity of disease, the patho-
logic features of M. tuberculosis infection in diabetic guinea
pigs differed from those in nondiabetic controls. These
changes may be related to the altered expression of partic-
ular cytokines and subsequent cellular response to M.
tuberculosis infection. Increased IL-17 levels, also
described in humans with type 2 diabetes and TB,50 as well
as elevated IL-8 expression, may be linked to more granu-
locytic inﬁltration and pathology seen in diabetic guinea1115
Podell et alpigs infected with M. tuberculosis. A persistent IL-17
response during TB contributes to excessive inﬂammation
and is generally limited by IFN-g production, although this
was not evident in the diabetic guinea pigs in this study.51,52
We have shown that the accumulation of AGEs occurs as
a result of M. tuberculosisemediated inﬂammation but
is further increased when combined with diabetes. This
response was reﬂected by the marked increase in serum
AGE levels only in diabetic guinea pigs with TB. These by-
products of chronic hyperglycemia, combined with oxida-
tive stress, induce a proinﬂammatory response and may
have contributed to the more severe inﬂammation and TB
disease in guinea pigs with type 2 diabetes.53e55 A signif-
icant increase in MCP-1 expression in diabetic guinea pigs
with TB correlated with the pattern of coalescing foci of
tissue macrophages without granuloma formation in the
spleen. Increased MCP-1 expression in patients with TB is a
feature of pulmonary TB; however, the increased expression
of this cytokine in diabetic guinea pigs may explain the
more severe, miliary pattern of extrapulmonary spread to the
spleen, which is prevalent in this species.56
It is generally accepted that a Th1-biased cytokine
response is critical for protection during M. tuberculosis
infection. Guinea pigs with type 2 diabetes displayed higher
macrophage activation, an appropriate response to the
increased production of IFN-g. Despite this seemingly
favorable response to M. tuberculosis infection, diabetic
guinea pigs failed to limit bacterial growth. A balance be-
tween the ability to limit bacterial growth and the devel-
opment of damaging inﬂammation during active TB may
explain the increase in anti-inﬂammatory cytokine levels.
The increased anti-inﬂammatory cytokine expression is
likely a reciprocal response intended to prevent host injury
from the exacerbated innate response to M. tuberculosis
infection seen in diabetic guinea pigs. In this study, the
increase in IL-10 occurred despite the counterregulatory
effects of high IFN-g expression. These ﬁndings suggest
possible IFN-gemediated induction of IL-10, as has been
previously described in association with a high M. tuber-
culosis burden.57,58 Previously, delayed onset of IFN-g
production in response to M. tuberculosis infection was
shown in STZ-treated mice with hyperglycemia, which also
fail to control bacterial growth.8 The contribution of rapid
disease progression before onset of adaptive immunity to M.
tuberculosis in diabetic patients needs to be determined in
future studies focusing on the very early stages of diabetes-
TB comorbidity in guinea pigs. Previous studies have
shown that the accumulation of regulatory T cells express-
ing FoxP3 during M. tuberculosis infection parallels the
activation of a Th1-biased adaptive immune response and,
along with the Th2 cytokine IL-4, is thought to impair a
productive Th1 lymphocyte response.59 However, in this
study, no differences were noted in FoxP3 or IL-4 expres-
sion, suggesting that the overexpression of immunosup-
pressive T-cell subsets is not a major determinant in the
increased severity of TB in guinea pigs with type 2 diabetes.1116From this and other studies investigating diabetes-TB
comorbidity, it is evident that the diabetic state impairs M.
tuberculosis host defenses, resulting in uncontrolled bacte-
rial growth. In addition, altered cytokine expression and
more severe pulmonary pathologic abnormalities indicative
of a proinﬂammatory response to M. tuberculosis infection
are consistent with features described in diabetes-TB co-
morbidity of humans. Moreover, these studies demonstrate
that M. tuberculosis infection alone is associated with
altered host lipid and glucose metabolism, which reveals the
possibility of using antiglycemic drugs as an adjunct with
antimicrobial drugs to treat TB. Because of the shared fea-
tures of M. tuberculosis infection in diabetic patients and
guinea pigs, this model will be valuable in testing new TB
treatments and diabetes control strategies when both dis-
eases occur together.
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